TREMFYA One-Press Patient Controlled Injector Approved for Plaque Psoriasis
The Janssen Pharma, a part of Johnson & Johnson, won FDA approval for its TREMFYA One-Press single-dose injector. The device is used to deliver TREMFYA (guselkumab) as a treatment for moderate to severe plaque psoriasis.
The TREMFYA One-Press al...
Source: Medgadget - Category: Medical Devices Authors: Editors Tags: Dermatology Medicine Source Type: blogs
More News: Dermatology | Medical Devices | Pharmaceuticals | Psoriasis | Skin | Study | Teaching | Universities & Medical Training